arthritis due to mycobacterium fortuitum.

NLM AIDSLINE Arthritis due to mycobacterium fortuitum. Butt AA; Janney A; Department of Medicine, Louisiana State University
July 30, 1999

Scand J Infect Dis. 1998;30(5):525-7. Unique Identifier : AIDSLINE Mycobacterium fortuitum is classified as a rapidly growing mycobacterium (RGM) according to the Runyon classification. RGM are increasingly being recognized as human pathogens. Joint infection due to M. fortuitum is a rare, but serious disease. This report describes a patient with acquired immunodeficiency syndrome (AIDS) and septic arthritis of the knee due to M. fortuitum in a previously normal joint with no history of surgery or intra-articular injections. JOURNAL ARTICLE Acquired Immunodeficiency Syndrome/COMPLICATIONS Adult Arthritis, Infectious/COMPLICATIONS/DIAGNOSIS/MICROBIOLOGY Case Report Human Knee Joint Male Mycobacterium fortuitum/ISOLATION & PURIF Mycobacterium Infections, Atypical/COMPLICATIONS/DIAGNOSIS

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Tentative approval of lamivudine and tenofovir disoproxil fumarate Tablets, 300 mg/300 mg Too many patients, too little time After a decade, global AIDS program looks ahead South Africa: Mandela name pulled into politics General Secretariat of the League of Arab States and UNAIDS to work toward an accelerated HIV response in the Arab Region HarborPath Receives $250,000 Elton John AIDS Foundation Grant to Support Program Expansion CANADA: Health Officials in St. John's N.L., Inform 50 People of Tuberculosis Risk OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland NEVADA: Clinics Offer Low-Cost Care for those Lacking Insurance Jury to be seated, Vegas hep C trial due to start GLOBAL: One-in-Four Deaths in Pregnancy Due to HIV in Worst-Affected Countries Advisory - Arbonne Men's Facial Moisturizer Recalled Due to Contamination Pharmaceutical Market Fails to Capture $188 Billion U.S. Revenue and $564 Billion Global Revenue Annually Due to Medication Non-Adherence AEGiS will be Offline November 26, 27, 2012 due to rolling power outages due to local power line maintenance UNITED STATES: Arthritis Drug May Cure Drug-Resistant TB Mylan Applauds Study Highlighting $1 Trillion in Savings for U.S. Health Care System Due to Generic Drugs Over Past Decade New Book says Tens of Millions of Young People Face AIDS Risk Due to Lack of Sex Education 20% people switch Atripla due to efavirenz side effects: late switches are common FDA announced approval of Rifabutin, a drug to prevent Mycobacterium avium complex (MAC) disease in people with advanced HIV infection
Information in this article was accurate in July 30, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.